August 8, 2022 Intelligence: Late-Breaking Lab News

One of the biggest health insurers in the United States has changed its name. As of June 28, Anthem in Indianapolis, Ind., is now known as Elevance Health. The new name is a combination of “elevate” and “advance,” noted Modern Health Executive on June 16. Elevance also announced Carelon as its new healthcare services brand and the return of Wellpoint for certain health insurance products, Forbes said on June 16. Prior to 2014, Anthem was called Wellpoint. The Anthem moniker will continue to be used for the company’s Blue Cross Blue Shield health plans.

MORE ON: Rebranding

Northwest Pathology in Bellingham, Wash., announced that with the December 2021 acquisition of Avero Diagnostics in Irving, Texas, the combined company will go by the Avero Diagnostics brand. Avero now employs 20 pathologists and offers services in Texas, Washington, and Alaska. 


As part of the federal effort to expand monkeypox testing capabilities in the country, the U.S. National Institute of Standards and Technology (NIST) has developed a material to help ensure the positive accuracy of diagnostic tests for the disease. NIST is making the material available for free to test manufacturers and testing labs. For more information, go to 


Labcorp in Burlington, N.C., plans to spin off its clinical development business into a new, publicly traded company that offers clinical trial management and related technology to pharmaceutical and biotech companies. Labcorp is hoping to complete the spinoff by the second half of 2023.


Anthony Guidi, MD, has been announced as the new Chief of Pathology at Brigham and Women’s Faulkner Hospital in Boston. Guidi will also continue to serve as the Chair of the Department of Pathology at Newton-Wellesley Hospital, an affiliated medical center in nearby Newton, Mass., where he has worked for 12 years.

• Cornerstone Diagnostics in Jamestown, Ky., named J. Dean Reed as the new Vice President of Sales and Business Development. Previously, Reed worked at Mayo Clinic Laboratories and Miraca Life Sciences.

Thomas Schinecker, PhD, CEO at Roche Diagnostics Division in Basel, Switzerland, will become the CEO of parent company Roche in March. He will succeed current chief executive Severin Schwan, who has been CEO at Roche since 2008. Schinecker has held several leadership roles at Roche since 2003.




You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.